secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001171843-25-003205
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology Q1 loss $2.3M; revenue up to $110k; cash position improves to $3.1M
--------------------------------------------------------------------------------

- Net loss from continuing ops $2.3M ($0.32 per share) vs $0.88 loss per share YoY.
- Revenue $110,310 vs $4,858 YoY, driven by completion of tumor-specific 3D model.
- Cash and equivalents $3.1M at March 31, 2025, up from $611k at Dec 31, 2024.
- Sold Skyline Medical assets to DeRoyal; sharpens focus on AI/ML drug discovery.
- Plans European launch of ChemoFx assay for ovarian/gynecological cancers; expanded US availability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184325003205/0001171843-25-003205-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184325003205/f8k_051425.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-003205

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer